Table 1 Clinical and laboratory data of the study participants
ESRD (n = 75) Mean ± SD | CKD (n = 75) Mean ± SD | Control (n = 40) Mean ± SD | P value | |
|---|---|---|---|---|
Age, years | 46.44 ± 13.97 | 49.16 ± 13.19 | 37.23 ± 15.07 | < 0.001 |
Males, no. (%) | 38 (50.7) | 27 (36.0) | 19 (47.5) | 0.174 |
DM, no. (%) | 25 (33.3%) | 27 (36%) | 13 (32.5%) | 0.912 |
HTN, no. (%) | 52 (69.3%) | 49 (65.3%) | 12 (30%) | < 0.001 |
Laboratory tests | ||||
Hb, g/dL | 8.50 ± 1.63 | 8.95 ± 1.85 | 11.18 ± 2.76 | < 0.001 |
Urea, mg/dL | 167.95 ± 71.22 | 133.42 ± 59.38 | 36.25 ± 17.85 | < 0.001 |
Creatinine, mg/dL | 9.09 ± 4.41 | 5.71 ± 2.89 | 0.87 ± 0.17 | < 0.001 |
eGFR | – | 12.37 ± 8.14 | 98.94 ± 25.53 | < 0.001 |
K, mEq/L | 4.47 ± 0.78 | 4.30 ± 0.71 | 4.23 ± 0.57 | 0.156 |
Mg, mEq/L | 2.00 ± 0.37 | 1.95 ± 0.23 | 1.98 ± 0.22 | 0.708 |
Ca, mg/L | 7.44 ± 1.24 | 7.90 ± 1.19 | 8.86 ± 0.60 | < 0.001 |
PO4, mEq/L | 6.13 ± 1.79 | 5.45 ± 1.64 | 3.38 ± 0.67 | < 0.001 |
PTH, pg/mL | 368.56 ± 198.75 | 283.17 ± 127.11 | 48.08 ± 16.24 | < 0.001 |
Iron, µg/dL | 56.04 ± 35.40 | 62.91 ± 33.20 | 69.52 ± 42.23 | 0.079 |
TIBC, µg/dL | 195.16 ± 42.11 | 183.21 ± 49.32 | 225.02 ± 104.46 | 0.122 |
Transferrin Sat, % | 29.72 ± 18.09 | 34.56 ± 15.21 | 36.28 ± 19.77 | 0.029 |
LVEF, % | 66.55 ± 6.99 | 65.70 ± 7.63 | 63.75 ± 6.61 | 0.170 |